Intended for the prevention of thrombotic events in patients with ACS.

For the potential treatment of panic and anxiety disorders.

Intended for the treatment of cervical dysplasia associated with the human papillomavirus (HPV).

Intended for the treatment of various forms of cancer.

Investigated for use/treatment in autoimmune diseases, eye disorders/infections, immunosuppressive, kidney transplant surgery, psoriasis and psoriatic disorders, rheumatoid ...

Intended for the treatment of brain cancer.

For the treatment of sexual dysfunction in women.

Investigated for use/treatment in infectious and parasitic disease (unspecified).

Investigated for use/treatment in infectious and parasitic disease (unspecified) and pediatric indications.

Investigated for use/treatment in bacterial infection and skin infections/disorders.

Investigated for use/treatment in liver disease, metabolic disease, and pediatric indications.

Intended for the treatment of various forms of cancer.

Intended for the treatment of various forms of cancer.

For the treatment of constipation-predominant irritable bowel syndrome (IBS-C).

For the treatment of serious bacterial infections in hospitalised patients.

Alfimeprase is being evaluated as a potential treatment for acute ischemic stroke, catheter occlusion (CO) and acute peripheral arterial occlusion (PAO).

For the treatment of hypertension.

For the treatment of multiple sclerosis (MS).

For the potential treatment of restless legs syndrome, or RLS, and neuropathic pain.

Investigated for use/treatment in gastrointestinal diseases and disorders (miscellaneous).